XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Shares Available for Issuance Under 2020 Plan

A summary of the shares available for issuance under the 2020 Plan is as follows:

 

 

Number of Shares

 

Balance at December 31, 2020

 

 

1,188

 

Authorized

 

 

547

 

Granted/Awarded

 

 

(672

)

Cancelled

 

 

20

 

Balance at September 30, 2021

 

 

1,083

 

Summary of Option Award Activity

Option award activity under the 2020 Plan is set forth below:

 

 

Options Outstanding

 

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (In Years)

 

 

Aggregate Intrinsic Value

 

Outstanding at December 31, 2020

 

 

 

 

$

 

 

 

 

 

$

 

Options granted

 

 

672

 

 

$

7.59

 

 

 

 

 

 

 

 

 

Options exercised

 

 

 

 

$

 

 

 

 

 

 

 

 

 

Options cancelled

 

 

(20

)

 

$

8.27

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2021

 

 

652

 

 

$

7.57

 

 

 

9.5

 

 

$

219

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at September 30, 2021

 

 

652

 

 

$

7.57

 

 

 

9.5

 

 

$

219

 

Vested and exercisable at September 30, 2021

 

 

60

 

 

$

7.77

 

 

 

9.6

 

 

$

7

 

Summary of Fair Value of Employee and Non-Employee Stock Options was Estimated Using Assumptions

The Company estimated the fair value of stock-options using the Black-Scholes option pricing model. The fair value of employee and non-employee stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of employee and non-employee stock options was estimated using the following assumptions for the three and nine months ended September 30, 2021:

 

 

Three Months Ended September 30, 2021

 

Nine Months Ended

September 30, 2021

Risk-free interest rate

 

0.8 - 1.1%

 

0.6 - 1.1%

Expected term (years)

 

6

 

6

Expected volatility

 

73%

 

72 - 73%

Dividends

 

0.0%

 

0.0%

Summary of Restricted Stock Award Activity

Restricted stock award activity under the 2020 Plan is set forth below:

 

 

Restricted Stock Awards Outstanding

 

 

 

Number of Units

 

 

Weighted Average Grant Date Fair Value Per Share

 

Non-vested at December 31, 2020

 

 

2,050

 

 

$

10.30

 

Restricted stock awards granted

 

 

 

 

$

 

Restricted stock awards vested

 

 

(598

)

 

$

10.34

 

Restricted stock awards cancelled

 

 

 

 

$

 

Non-vested at September 30, 2021

 

 

1,452

 

 

$

10.28

 

Summary of Total Stock-Based Compensation Expense Recognized

The following table sets forth the total stock-based compensation expense recognized under the 2020 Plan, the 2020 ESPP and the Phantom Stock Plan in the Company’s condensed statements of operations:

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Cost of revenue – product

 

$

46

 

 

$

130

 

 

$

168

 

 

$

130

 

Cost of revenue – service

 

 

27

 

 

 

70

 

 

 

95

 

 

 

70

 

Selling, general and administrative expenses

 

 

1,373

 

 

 

3,179

 

 

 

4,580

 

 

 

3,267

 

Research and development expenses

 

 

127

 

 

 

370

 

 

 

480

 

 

 

370

 

Total

 

$

1,573

 

 

$

3,749

 

 

$

5,323

 

 

$

3,837

 

Summary of Unrecognized Stock-based Compensation Expense Expected to be Amortized

Total unrecognized stock-based compensation expense is expected to be amortized as follows:

Fiscal Year

 

Amount

 

Remainder of 2021

 

$

1,500

 

2022

 

 

5,606

 

2023

 

 

3,495

 

2024

 

 

469

 

2025

 

 

97

 

Thereafter

 

 

 

Total unrecognized stock-based compensation expense

 

$

11,167